
Veeva Systems (VEEV) Stock Forecast & Price Target
Veeva Systems (VEEV) Analyst Ratings
Bulls say
Veeva Systems is a dominant player in the life sciences industry, with a large and expanding market opportunity. The company's best-of-breed offerings and strong domain expertise allow it to efficiently and compliantly serve customers ranging from small biotech companies to global pharmaceutical manufacturers. With a track record of solid financial performance and a strong outlook for future growth, Veeva is a compelling investment.
Bears say
Veeva Systems is facing several challenges that could have a negative impact on its financial performance. Despite beating revenue and earnings expectations, the company's reliance on the life sciences industry makes it vulnerable to any downturns or regulatory changes in that sector. Additionally, the expected slowdown in subscription revenue and challenges in its R&D segment could hinder future growth potential. Furthermore, any unexpected hurdles in integrating its recent acquisition of Gentiva could also negatively affect the company's financials. As such, there is a potential for multiple compression in the company's SaaS space, posing risks to its stock value.
This aggregate rating is based on analysts' research of Veeva Systems and is not a guaranteed prediction by Public.com or investment advice.
Veeva Systems (VEEV) Analyst Forecast & Price Prediction
Start investing in Veeva Systems (VEEV)
Order type
Buy in
Order amount
Est. shares
0 shares